Claro Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Claro Advisors's LLY Position: Q1 2026 in Review
Claro Advisors increased its Eli Lilly (LLY) stake by 20% in Q1 2026, buying an estimated $642K and bringing the position to 3,768 shares worth $3.47M. The position accounts for 0.42% of the portfolio, ranked #53.
Claro Advisors first reported a position in LLY in Q4 2018 and has held it in 21 quarters since. The position peaked at $3.73M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Claro Advisors held 3,768 shares of Eli Lilly worth $3.47M as of Q1 2026.
- Claro Advisors bought 633 Eli Lilly shares in Q1 2026, an estimated $642K.
- Eli Lilly made up 0.42% of Claro Advisors's portfolio in Q1 2026, its #53 holding.
- Claro Advisors first reported a position in Eli Lilly in Q4 2018 and has held it in 21 quarters since.
- Claro Advisors's Eli Lilly position peaked at $3.73M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.